Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors

被引:30
作者
Gurung, I. S. [2 ]
Martinez-Pinna, J. [3 ]
Mahaut-Smith, M. P. [1 ,2 ]
机构
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
[2] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England
[3] Univ Alicante, Div Fisiol, E-03080 Alicante, Spain
基金
英国医学研究理事会;
关键词
G-protein-coupled receptor; voltage-dependence; antagonist; calcium; P2Y(1);
D O I
10.1038/bjp.2008.97
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Emerging evidence suggests that activation of G-protein-coupled receptors (GPCRs) can be directly regulated by membrane voltage. However, the physiological and pharmacological relevance of this effect remains unclear. We have further examined this phenomenon for P2Y(1) receptors in the non-excitable megakaryocyte using a range of agonists and antagonists. Experimental approach: Simultaneous whole-cell patch clamp and fura-2 fluorescence recordings of rat megakaryocytes, which lack voltage-gated Ca2+ influx, were used to examine the voltage-dependence of P2Y(1) receptor-evoked IP3-dependent Ca2+ mobilization. Results: Depolarization transiently and repeatedly enhanced P2Y(1) receptor-evoked Ca2+ mobilization across a wide concentration range of both weak, partial and full, potent agonists. Moreover, the amplitude of the depolarization-evoked [Ca2+](i) increase displayed an inverse relationship with agonist concentration, such that the greatest potentiating effect of voltage was observed at near-threshold levels of agonist. Unexpectedly, depolarization also stimulated an [Ca2+](i) increase in the absence of agonist during exposure to the competitive antagonists A3P5PS and MRS2179, or the allosteric enhancer 2,2'-pyridylisatogen tosylate. A further effect of some antagonists, particularly suramin, was to enhance the depolarization-evoked Ca2+ responses during co-application of an agonist. Of several P2Y(1) receptor inhibitors, only SCH202676, which has a proposed allosteric mechanism of action, could block ADP-induced voltage-dependent Ca2+ release. Conclusions and implications: The ability of depolarization to potentiate GPCRs at near-threshold agonist concentrations represents a novel mechanism for coincidence detection. Furthermore, the induction and enhancement of voltage- dependent GPCR responses by antagonists has implications for the design of therapeutic compounds.
引用
收藏
页码:882 / 889
页数:8
相关论文
共 43 条
[11]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[12]   The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y1 receptor antagonists [J].
Coddou, C ;
Loyola, G ;
Boyer, JL ;
Bronfman, M ;
Huidobro-Toro, JP .
FEBS LETTERS, 2003, 536 (1-3) :145-150
[13]  
Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924
[14]   Imaging calcium dynamics in dendritic spines [J].
Denk, W ;
Yuste, R ;
Svoboda, K ;
Tank, DW .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (03) :372-378
[15]   SCH-202676: An allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors [J].
Fawzi, AB ;
Macdonald, D ;
Benbow, LL ;
Smith-Torhan, A ;
Zhang, HT ;
Weig, BC ;
Ho, G ;
Tulshian, D ;
Linder, ME ;
Graziano, MP .
MOLECULAR PHARMACOLOGY, 2001, 59 (01) :30-37
[16]   MEMBRANE-POTENTIAL MODULATES INOSITOL 1,4,5-TRISPHOSPHATE-MEDIATED CA2+ TRANSIENTS IN GUINEA-PIG CORONARY MYOCYTES [J].
GANITKEVICH, VY ;
ISENBERG, G .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 470 :35-44
[17]   2,2′-pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding [J].
Gao, ZG ;
Mamedova, L ;
Tchilibon, S ;
Gross, AS ;
Jacobson, KA .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) :231-237
[18]   Effects of the allosteric modulator SCH-202676 on adenosine and P2Y receptors [J].
Gao, ZG ;
Gross, AS ;
Jacobson, KA .
LIFE SCIENCES, 2004, 74 (25) :3173-3180
[19]   EFFECTS OF ANALOGS OF ADENINE-NUCLEOTIDES ON INCREASES IN INTRACELLULAR CALCIUM MEDIATED BY P2T-PURINOCEPTORS ON HUMAN BLOOD-PLATELETS [J].
HALL, DA ;
HOURANI, SMO .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :728-733
[20]   ATP derivatives are antagonists of the P2Y1 receptor:: Similarities to the platelet ADP receptor [J].
Hechler, B ;
Vigne, P ;
Léon, C ;
Breittmayer, JP ;
Gachet, C ;
Frelin, C .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :727-733